Development of an immune-related prognostic biomarker for triple-negative breast cancer-Reference-Cited by-同舟云学术

Development of an immune-related prognostic biomarker for triple-negative breast cancer

Published:2022-04-28 Issue:1 Volume:54 Page:1212-1220
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Zhang Yan¹²^ORCID,Wang Quan³^ORCID,Yang Wei-Kang⁴^ORCID,Wang Yong-Si⁵^ORCID,Zhou Qiao⁶^ORCID,Lin Jie⁷^ORCID,Wei Xu-Xuan¹^ORCID,Liang Tian¹^ORCID,Liu Tongtong³^ORCID,Fan Wen-Tao⁵^ORCID,Liang Li⁷⁸^ORCID,Xu You-Nian⁶⁹^ORCID

Affiliation:

1. Department of Pathology, The First Affiliated Hospital of Guangdong University of Pharmacy, Guangzhou, China

2. Department of Pathology, Maternity & Child Healthcare Hospital of Longhua District, Shenzhen, China

3. College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China

4. Department of Prevention and Health Care, Maternity & Child Healthcare Hospital of Longhua District, Shenzhen, China

5. Guangzhou Huayin Medical Laboratory Center. Ltd, Guangzhou, China

6. Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

7. Department of Pathology, Nanfang Hospital, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China

8. Guangdong Province Key Laboratory of Molecular Tumor Pathology, Guangzhou, China

9. Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Funder

National Key R&D Program of China #1

The Science Foundation of Shenzhen Science and Technology Innovation Committee #2

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2067894

Reference20 articles.

1. The globalisation of cancer

2. Genetic Markers in Triple-Negative Breast Cancer